The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients.
Liangqiang LiJing YuKunwei ShenXiaosong ChenPublished in: Journal of breast cancer (2024)
The 21-gene RS assay improved the MDT compliance rate in patients with early breast cancer. Adherence to MDT is associated with a better prognosis.
Keyphrases
- epidermal growth factor receptor
- early breast cancer
- tyrosine kinase
- high throughput
- advanced non small cell lung cancer
- copy number
- genome wide
- endothelial cells
- genome wide identification
- induced pluripotent stem cells
- type diabetes
- combination therapy
- gene expression
- adipose tissue
- metabolic syndrome
- skeletal muscle
- pluripotent stem cells
- smoking cessation